What is the Market's View on ICU Medical Inc (ICUI) Stock's Price and Volume Trends Tuesday?

Overall market sentiment has been high on ICU Medical Inc (ICUI) stock lately. ICUI receives a Bullish rating from InvestorsObserver Stock Sentiment Indicator.

ICU Medical Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on ICUI!

See Full ICUI Report

What is Stock Sentiment?

Sentiment uses short term technical analysis to gauge whether a stock is desired by investors. As a technical indicator, it focuses on recent trends as opposed to the long term health of the underlying company. Updates for the company such as a earnings release can move the stock away from current trends. Recent trends are a good indicator of current market sentiments. In its most basic form, stocks that are trending up are desirable by investors while stocks currently falling must be unattractive. InvestorsObserver's Sentimental Indicator tracks both changes in price and volume to analyze the most recent trends. Typically an increase in volume indicates ongoing trends are getting stronger, while a decrease in volume usually signals an end to the current trend. Available options can also represent current sentiments for a given stock. Since investors are able to bet on future trends of stocks using options, we consider the ratio of calls to puts when analyzing market sentiments .

What's Happening With ICUI Stock Today?

ICU Medical Inc (ICUI) stock is trading at $166.08 as of 11:52 AM on Tuesday, Aug 9, a decline of -$22.02, or -11.71% from the previous closing price of $188.10. The stock has traded between $164.50 and $172.18 so far today. Volume today is above average. So far 420,833 shares have traded compared to average volume of 175,873 shares. To screen for more stocks like ICU Medical Inc click here.

More About ICU Medical Inc

ICU Medical is a California-based, pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. After ICU's acquisition of Hospira Infusion Systems from Pfizer in 2017, it became one of the largest players in this concentrated industry, holding top-tier positions in its major reporting segments: infusion consumables (37% of 2020 revenue), IV solutions (31%), infusion systems (28%), and critical care (4%). The combined entity remains primarily U.S. focused, generating over 70% of its sales domestically. Click Here to get the full Stock Report for ICU Medical Inc stock.